• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于周边角膜有效交联的治疗方案的识别:一项实验研究。

Identification of Treatment Protocols for Effective Cross-Linking of the Peripheral Cornea: An Experimental Study.

作者信息

Donner Ruth, Laggner Maria, Aschauer Julia, Lammer Jan, Schmidinger Gerald

机构信息

Department of Ophthalmology, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.

Department of Thoracic Surgery, Medical University of Vienna, Vienna, Austria.

出版信息

Ophthalmol Ther. 2022 Dec;11(6):2057-2066. doi: 10.1007/s40123-022-00564-1. Epub 2022 Sep 6.

DOI:10.1007/s40123-022-00564-1
PMID:36066843
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9587201/
Abstract

INTRODUCTION

This study aimed to test and evaluate modified corneal cross-linking (CXL) protocols regarding improved treatment effects on the peripheral cornea in terms of tissue stability and cellular response.

METHODS

Peripheral CXL (pCXL) was performed within a ring of 9-11 mm of 36 human donor corneas with variations in applied energy (5.4, 7.2, and 10 J/cm) at 9 mW/cm irradiance. Each energy level was additionally modulated regarding the oxygen level surrounding the cornea during treatment (21%; 100%). Stress-strain tests with endpoints at 12% strain and collagenase A-assisted digestions to complete digestion were performed to evaluate the rigidity and resistance of treated and control tissue. Further, corneas were processed histologically via TUNEL assay and H&E staining to demonstrate the effects on stromal cells during treatment under varying CXL conditions.

RESULTS

Increases in energy dosage achieved significant increases in resistance to stress in all variations except when comparing protocols A and B under normoxic conditions. Supplemental oxygen significantly increased rigidity in protocols B (p < 0.01) and C (p = 0.018). Hyperoxic conditions significantly increased resistance to digestion in all protocols. The number of DNA strand breaks in TUNEL assay staining showed significant increases in all increases in energy as well as with oxygen supplementation.

CONCLUSIONS

Increases in energy and supplemental oxygen improved the effect of CXL, though endothelial safety could not be verified with confidence in high-fluence CXL with supplemental oxygen. Results suggest that CXL protocols using 7.2 J/cm with 100% O or 10 J/cm without supplemental oxygen prove most effective without anticipated risk of endothelial damage.

摘要

引言

本研究旨在测试和评估改良的角膜交联(CXL)方案,该方案在组织稳定性和细胞反应方面对周边角膜具有更好的治疗效果。

方法

对36个人类供体角膜9 - 11毫米环内进行周边角膜交联(pCXL),在9 mW/cm辐照下应用不同能量(5.4、7.2和10 J/cm)。每个能量水平在治疗期间还根据角膜周围的氧气水平进行调节(21%;100%)。进行应变为12%时的应力 - 应变测试以及胶原酶A辅助消化直至完全消化,以评估处理过的组织和对照组织的硬度和抗性。此外,通过TUNEL检测和苏木精 - 伊红(H&E)染色对角膜进行组织学处理,以证明在不同CXL条件下治疗期间对基质细胞的影响。

结果

除了在常氧条件下比较方案A和B时,能量剂量的增加在所有变体中均显著提高了抗应力能力。补充氧气在方案B(p < 0.01)和方案C(p = 0.018)中显著提高了硬度。高氧条件在所有方案中均显著提高了抗消化能力。TUNEL检测染色中DNA链断裂的数量在所有能量增加以及补充氧气时均显著增加。

结论

能量增加和补充氧气改善了CXL的效果,尽管在补充氧气的高能量CXL中无法确定内皮安全性。结果表明,使用7.2 J/cm且100%氧气或10 J/cm且不补充氧气的CXL方案被证明是最有效的,且没有预期的内皮损伤风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c7/9587201/4406984099a9/40123_2022_564_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c7/9587201/2c49c1f4363f/40123_2022_564_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c7/9587201/3f1f553913ae/40123_2022_564_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c7/9587201/5a5a49c819e1/40123_2022_564_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c7/9587201/81172abcacc9/40123_2022_564_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c7/9587201/4406984099a9/40123_2022_564_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c7/9587201/2c49c1f4363f/40123_2022_564_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c7/9587201/3f1f553913ae/40123_2022_564_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c7/9587201/5a5a49c819e1/40123_2022_564_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c7/9587201/81172abcacc9/40123_2022_564_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f0c7/9587201/4406984099a9/40123_2022_564_Fig5_HTML.jpg

相似文献

1
Identification of Treatment Protocols for Effective Cross-Linking of the Peripheral Cornea: An Experimental Study.用于周边角膜有效交联的治疗方案的识别:一项实验研究。
Ophthalmol Ther. 2022 Dec;11(6):2057-2066. doi: 10.1007/s40123-022-00564-1. Epub 2022 Sep 6.
2
Corneal elasticity after oxygen enriched high intensity corneal cross linking assessed using atomic force microscopy.使用原子力显微镜评估富氧高强度角膜交联后的角膜弹性。
Exp Eye Res. 2016 Dec;153:51-55. doi: 10.1016/j.exer.2016.10.008. Epub 2016 Oct 8.
3
High-Fluence Accelerated Epithelium-Off Corneal Cross-Linking Protocol Provides Dresden Protocol-Like Corneal Strengthening.高剂量加速上皮下角膜交联方案提供与德累斯顿方案类似的角膜增强效果。
Transl Vis Sci Technol. 2021 Apr 29;10(5):10. doi: 10.1167/tvst.10.5.10.
4
Optimization of Oxygen Dynamics, UV-A Delivery, and Drug Formulation for Accelerated Epi-On Corneal Crosslinking.优化氧动力学、UV-A 递送和药物配方,以加速 Epi-On 角膜交联。
Curr Eye Res. 2020 Apr;45(4):450-458. doi: 10.1080/02713683.2019.1669663. Epub 2019 Oct 2.
5
Oxygen Diffusion May Limit the Biomechanical Effectiveness of Iontophoresis-Assisted Transepithelial Corneal Cross-linking.氧扩散可能会限制离子电渗疗法辅助的经上皮角膜交联的生物力学有效性。
J Refract Surg. 2018 Nov 1;34(11):768-774. doi: 10.3928/1081597X-20180830-01.
6
Biomechanical efficacy of contact lens-assisted collagen cross-linking in porcine eyes.角膜接触镜辅助胶原交联术在猪眼生物力学效果的研究。
Acta Ophthalmol. 2019 Feb;97(1):e84-e90. doi: 10.1111/aos.13828. Epub 2018 Nov 12.
7
Corneal biomechanical properties at different corneal cross-linking (CXL) irradiances.不同角膜交联(CXL)辐照强度下的角膜生物力学特性。
Invest Ophthalmol Vis Sci. 2014 May 2;55(5):2881-4. doi: 10.1167/iovs.13-13748.
8
Increased Biomechanical Efficacy of Corneal Cross-linking in Thin Corneas Due to Higher Oxygen Availability.由于氧气供应更充足,薄角膜的角膜交联生物力学效果增强。
J Refract Surg. 2015 Dec;31(12):840-6. doi: 10.3928/1081597X-20151111-08.
9
A case of in vivo iontophoresis-assisted corneal collagen cross-linking for keratoconus: An immunohistochemical study.一例体内离子导入辅助角膜胶原交联治疗圆锥角膜的免疫组织化学研究。
Acta Histochem. 2017 Apr;119(3):343-347. doi: 10.1016/j.acthis.2017.02.001. Epub 2017 Feb 16.
10
Corneal Cross-Linking with Riboflavin and UV-A in the Mouse Cornea in Vivo: Morphological, Biochemical, and Physiological Analysis.体内小鼠角膜中核黄素与紫外线A诱导的角膜交联:形态学、生物化学和生理学分析
Transl Vis Sci Technol. 2017 Jan 30;6(1):7. doi: 10.1167/tvst.6.1.7. eCollection 2017 Jan.

引用本文的文献

1
The Efficiency and Safety of Oxygen-Supplemented Accelerated Scleral Cross-Linking in Rabbits.兔眼补充氧气加速巩膜交联的有效性和安全性
Invest Ophthalmol Vis Sci. 2025 Jun 2;66(6):10. doi: 10.1167/iovs.66.6.10.
2
Corneal Resistance to Enzymatic Digestion After Rose Bengal and Combined Rose Bengal/Riboflavin Cross-Linking Is Oxygen Independent.孟加拉玫瑰红及联合使用孟加拉玫瑰红/核黄素交联后角膜对酶消化的抵抗力与氧气无关。
Transl Vis Sci Technol. 2025 Mar 3;14(3):1. doi: 10.1167/tvst.14.3.1.
3
Monitoring the Effectiveness of High-Fluence Peripheral Crosslinking for Corneal Neovascularization with Anterior Segment Optical Coherence Tomography Angiography.

本文引用的文献

1
Corneal Cross-Linking for Keratoconus and Post-LASIK Ectasia and Failure Rate: A 3 Years Follow-Up Study.圆锥角膜和准分子激光原位角膜磨镶术后角膜扩张的角膜交联术及失败率:一项3年随访研究
Cureus. 2021 Nov 13;13(11):e19552. doi: 10.7759/cureus.19552. eCollection 2021 Nov.
2
Risk Factors for Progression of Keratoconus and Failure Rate After Corneal Cross-linking.圆锥角膜进展的危险因素和角膜交联术后的失败率。
J Refract Surg. 2021 Dec;37(12):816-823. doi: 10.3928/1081597X-20210830-01. Epub 2021 Dec 1.
3
Peripheral corneal thickness and associated factors - results from the population-based German Gutenberg Health Study.
使用眼前节光学相干断层扫描血管造影术监测高流量周边交联治疗角膜新生血管的有效性。
J Clin Med. 2024 Jun 28;13(13):3804. doi: 10.3390/jcm13133804.
周边角膜厚度及其相关因素 - 基于人群的德国哥廷根健康研究结果。
Acta Ophthalmol. 2022 Sep;100(6):e1298-e1305. doi: 10.1111/aos.15057. Epub 2021 Nov 10.
4
Long-term visual, anterior and posterior corneal changes after crosslinking for progressive keratoconus.交联治疗进展性圆锥角膜后的长期视力、前房和后角膜变化。
Eur J Ophthalmol. 2022 Jan;32(1):50-58. doi: 10.1177/11206721211052878. Epub 2021 Oct 30.
5
Corneal Collagen Cross-Linking Pretreatment Mitigates Injury-Induced Inflammation, Hemangiogenesis and Lymphangiogenesis In Vivo.角膜胶原交联预处理减轻体内损伤诱导的炎症、血管生成和淋巴管生成。
Transl Vis Sci Technol. 2021 Apr 29;10(5):11. doi: 10.1167/tvst.10.5.11.
6
Corneal Cross-linking for Progressive Keratoconus in Patients Older Than 40 Years: Long-term Follow-up.40 岁以上进展性圆锥角膜患者的角膜交联术:长期随访。
J Refract Surg. 2021 May;37(5):338-342. doi: 10.3928/1081597X-20210210-01. Epub 2021 May 1.
7
Corneal Crosslinking to Regress Pathologic Corneal Neovascularization Before High-Risk Keratoplasty.角膜交联术在高危角膜移植术前消退病理性角膜新生血管。
Cornea. 2021 Feb 1;40(2):147-155. doi: 10.1097/ICO.0000000000002406.
8
Peripheral Cornea Crosslinking Before Deep Anterior Lamellar Keratoplasty.深板层角膜移植术前的周边角膜交联术
Med Hypothesis Discov Innov Ophthalmol. 2020 Summer;9(2):127-134. Epub 2020 Mar 27.
9
Endothelial Safety and Efficacy of Ex Vivo Collagen Cross-linking of Human Corneal Transplants.人眼角膜移植的体外胶原交联的内皮安全性和效果。
Am J Ophthalmol. 2020 Jun;214:127-133. doi: 10.1016/j.ajo.2020.02.024. Epub 2020 Mar 12.
10
Characteristics and risk factors of recurrent keratoconus over the long term after penetrating keratoplasty.穿透性角膜移植术后长期复发性圆锥角膜的特征及危险因素
Graefes Arch Clin Exp Ophthalmol. 2018 Dec;256(12):2377-2383. doi: 10.1007/s00417-018-4131-5. Epub 2018 Sep 8.